AnalystsDev PrasadDev Prasad's Stock Forecasts
AnalystsDev Prasad
Sectors:
Industries:
Analyst Ranking
Top 28%
#1524 out of 5511 analysts
Average Return
+48.97%
Win Rate
60%6 out of 10
Risk vs Reward
Poor
Good
Dev Prasad's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Opus Genetics IncIRD | +322.08% | $0.92 | $3.90 | 2025-06-17 - 2026-06-16 | Strong Buy |
Avalo Therapeutics IncAVTX | +100.64% | $9.38 | $18.82 | 2024-12-17 - 2025-12-16 | Strong Buy |
Calcimedica IncCALC | +87.77% | $13.90 | $26.10 | 2024-12-17 - 2025-12-16 | Strong Buy |
Quoin Pharmaceuticals LtdQNRX | +6.92% | $6.36 | $6.80 | 2026-05-04 - 2026-09-15 | Strong Buy |
Polaryx Therapeutics IncPLYX | +4.34% | $1.96 | $2.05 | 2026-07-27 - 2026-09-15 | Strong Buy |
Dev Prasad Analyst Color
Get additional color on Dev Prasad's coverage of popular stocks
Dev Prasad's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Faeth Therapeutics IncFTH | 1 | Strong Buy | $59.00 | +66.81% | Initiates Coverage On | 2 days ago |
Adlai Nortye Group LtdANL | 1 | Strong Buy | $49.00 | +226.67% | Assumes | 8 days ago |
Eloxx Pharmaceuticals IncELOX | 1 | Strong Buy | $38.00 | +108.22% | Initiates Coverage On | a month ago |
Polaryx Therapeutics IncPLYX | 1 | Strong Buy | $7.00 | +242.30% | Initiates Coverage On | 2 months ago |
Quoin Pharmaceuticals LtdQNRX | 1 | Strong Buy | $30.00 | +341.18% | Initiates Coverage On | 4 months ago |
Atyr Pharma IncATYR | 1 | Hold | $1.00 | N/A | Downgrades | a year ago |
Cue Biopharma IncCUE | 1 | Strong Buy | $120.00 | N/A | Initiates Coverage On | a year ago |
Opus Genetics IncIRD | 1 | Strong Buy | $5.00 | N/A | Initiates Coverage On | a year ago |
Avalo Therapeutics IncAVTX | 1 | Strong Buy | $24.00 | N/A | Initiates Coverage On | 2 years ago |
Ibio IncIBIO | 1 | Strong Buy | $6.00 | N/A | Initiates Coverage On | 2 years ago |
Calcimedica IncCALC | 1 | Strong Buy | $65.00 | N/A | Initiates Coverage On | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.